No they don't as yet With Due Diligence now completed IGS and its advisers will be rapidly finalising formal documentation associated with the transaction, which has been advancing concurrent to Due Diligence.
- Winter Garden Biosciences has taken delivery of its first 1,000 kgs of seed and commenced planting of its maiden crop and preparation for control work in greenhouses
Once the Due Dilligence is done IGS will be in a great position,
Winter Garden Bioscience is fully licensed to export cannabinoid products, including its high-potency CBD extracts. The Company plans to primarily target wholesale distribution partners which have developed CBD based product lines in the United States, Canada and Europe. This includes pharmaceutical and nutraceutical companies, in addition to companies focused on the marijuana marketplace. Winter Garden will also look at making its products available to retail consumers in North America and Europe which will supplement its wholesale revenues.
IGS Price at posting:
0.2¢ Sentiment: Buy Disclosure: Held